What are the side effects of Comirnaty?

Common Side Effects of Comirnaty

Comirnaty, also known as Pfizer-BioNTech COVID-19 Vaccine, is an mRNA-based vaccine developed to protect against COVID-19. Like all vaccines, Comirnaty can cause side effects, some of which can be mild and temporary, while others can be more severe [1].

According to the Centers for Disease Control and Prevention (CDC), common side effects of Comirnaty reported to the Vaccine Adverse Event Reporting System (VAERS) include:

- Pain, redness, or swelling at the injection site
- Fatigue
- Headache
- Muscle pain
- Chills
- Fever
- Nausea
- Tiredness
- Diarrhea
- Vomiting

These side effects are typically mild and resolve on their own within a few days [2].

Less Common Side Effects

Some side effects may be more severe and less common. These include:

- Allergic reactions (such as hives or difficulty breathing)
- High fever
- Decreased lymphocytes
- Decreased platelet count
- Decreased white blood cell count
- Increased risk of blood clots
- Guillain-Barré Syndrome (a rare autoimmune disorder)

If you experience any unusual or severe side effects after receiving Comirnaty, it's essential to seek medical attention [3].

Precautions and Contraindications

Comirnaty has certain warnings and precautions, including:

- Individuals with a history of severe allergic reactions to any component of the vaccine should not receive Comirnaty.
- People with certain medical conditions, such as a weakened immune system or bleeding disorders, should speak with their healthcare provider before receiving the vaccine.
- Pregnant or breastfeeding women should consult their healthcare provider before getting vaccinated.

It's essential to discuss the benefits and risks of Comirnaty with your healthcare provider if you have any concerns or questions.

Regulatory and Clinical Data

The safety and efficacy of Comirnaty have been evaluated in numerous clinical trials, including the pivotal Phase 3 trial, with over 43,000 participants (ages 12 and older) in the United States [4].

Patent Expiry

Comirnaty, as an mRNA-based vaccine, is a proprietary product. While specific information on patent expiry is not publicly available, DrugPatentWatch.com provides detailed information on patent-related data for pharmaceuticals.

References:

[1] Centers for Disease Control and Prevention. (n.d.). COVID-19 Vaccines. Retrieved from https://www.cdc.gov/coronavirus/2019-ncov/vaccines/index.html

[2] Centers for Disease Control and Prevention. (2022). Vaccine Adverse Event Reporting System (VAERS). Retrieved from https://vaers.hhs.gov/data/login.do

[3] Pfizer-BioNTech COVID-19 Vaccine (Comirnaty). (n.d.). Prescribing Information. Retrieved from https://www.covid19vaccineus.com/assets/ComirnatyPIUS.pdf

[4] Polack, F. P., et al. (2020). Safety and Efficacy of the BNT162b2 SARS-CoV-2 mRNA Vaccine. New England Journal of Medicine, 383(27), e69-e79.